Ajupharm is a company that focuses on developing novel therapeutic strategies. They have recently entered into a licensing agreement for RBM-007, a treatment for exudative age-related macular degeneration.
Ajupharm is a company that focuses on developing novel therapeutic strategies. They have recently entered into a licensing agreement for RBM-007, a treatment for exudative age-related macular degeneration.
